PureTech Net Income From Continuing Ops from 2010 to 2026
| PRTC Stock | 126.20 0.40 0.32% |
Net Income From Continuing Ops | First Reported 2010-12-31 | Previous Quarter 31.9 M | Current Value 33.5 M | Quarterly Volatility 103.8 M |
Check PureTech Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PureTech Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.7 M, Interest Expense of 12.1 M or Selling General Administrative of 27.2 M, as well as many indicators such as . PureTech financial statements analysis is a perfect complement when working with PureTech Health Valuation or Volatility modules.
PureTech | Net Income From Continuing Ops |
The evolution of Net Income From Continuing Ops for PureTech Health plc provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how PureTech Health compares to historical norms and industry peers.
Latest PureTech Health's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of PureTech Health plc over the last few years. It is PureTech Health's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PureTech Health's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
PureTech Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (4,822,231) | |
| Geometric Mean | 30,080,852 | |
| Coefficient Of Variation | (2,152) | |
| Mean Deviation | 57,414,379 | |
| Median | (5,584,000) | |
| Standard Deviation | 103,750,811 | |
| Sample Variance | 10764.2T | |
| Range | 447.7M | |
| R-Value | 0.15 | |
| Mean Square Error | 11237.9T | |
| R-Squared | 0.02 | |
| Significance | 0.58 | |
| Slope | 2,995,064 | |
| Total Sum of Squares | 172227.7T |
PureTech Net Income From Continuing Ops History
About PureTech Health Financial Statements
PureTech Health shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although PureTech Health investors may analyze each financial statement separately, they are all interrelated. The changes in PureTech Health's assets and liabilities, for example, are also reflected in the revenues and expenses on on PureTech Health's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 31.9 M | 33.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for PureTech Stock Analysis
When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.